logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Xima Medical (03309.HK) spent 368,700 Hong Kong dollars to repurchase 200,000 shares on November 14th.

date
14/11/2025
Zhtng Cijng APP news, Heimei Medical (03309.HK) announced that on November 14, 2025, the company spent 367,000 Hong Kong dollars to repurchase 200,000 shares, with a repurchase price of 1.83-1.85 Hong Kong dollars per share.
Latest
2 m ago
263: Controlling shareholder Li Xiaolong intends to reduce holdings by 1%.
2 m ago
Guangdong releases shopping and food maps to stimulate winter consumption market.
2 m ago
The shareholder of Bei Qingsong (688793.SH), Ma Xuejun, plans to transfer 2.97% of the company's shares through inquiry.
2 m ago
Trump plans to significantly reduce food tariffs, and multiple Latin American trade agreements will help reduce prices.
2 m ago
International Media Telegraph Agency: The head of the Russian national atomic energy company stated that due to the attack, some units are disconnected from the grid.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.